CLINICAL_TRIALS
trial_result
· 2020-04-08
Clinical Trial Update: A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA [Phase 3]
Summary
Phase I/III trial comparing subcutaneous CT-P13 to intravenous CT-P13 in active rheumatoid arthritis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celltrion | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2020-04-08